Topic:

Biomarkers

Latest Headlines

Latest Headlines

Qiagen licenses biomarker for rare blood disorders with a molecular Dx in mind

Qiagen snatched up a biomarker from an Austrian research group that will aid in the development of a test designed to better diagnose rare blood disorders.

Breast cancer gene BRCA1 linked to brain development

A harmful gene mutation that increases a woman's risk of developing breast and ovarian cancer may also play a role in brain development, according to new findings by scientists at the Salk Institute for Biological Studies.

Scripps scientists say new biomarker for various cancers might be more useful

Another newly discovered biomarker is now under consideration as a tool to help evaluate and treat disease. When the body expresses it, it appears to be tied to better survival chances in both non-small cell lung cancer and head and neck cancer.

Finding: 2 biomarkers for head and neck cancer can help predict radiation therapy resistance

International researchers led by Michigan's Beaumont Health System discovered two biomarkers that helped predict resistance to radiation therapy for patient's with squamous cell cancer of the head and neck.

U.K. team scores with blood test that might spot children likely to become obese

U.K. researchers have made advances developing a blood test that could screen for patients who have a genetic predisposition to obesity. Their work, published in the journal Diabetes, involves a team from the University of Southampton, University of Exeter Medical School and elsewhere.

New septic shock biomarker Dx could produce better care and smoother drug trials

A new diagnostic test screens for 5 protein biomarkers that can help differentiate septic shock patients at high or low risk for death. If further testing supports the initial findings, doctors will gain a tool to help them determine which patients need experimental therapies and which should get more traditional treatment.

CTC levels could provide a prostate cancer survival clue

New research supports the use of a circulating tumor cell blood test, rather than the standard PSA biomarker diagnostic, to predict a patient's odds of surviving prostate cancer.

Two Alzheimer's biomarker studies spur hope for earlier-stage diagnosis

Two separate research teams say they've made new biomarker discoveries that could help boost early detection and treatment of Alzheimer's disease in different ways.

Four new biomarkers may enable an earlier stomach cancer diagnosis

Australian researchers say they've zeroed in on four new biomarkers that could enable a simple blood test for the early diagnosis of stomach cancer, far earlier and more precise than existing standards of care.

Waters Corp. will help develop a blood-based biomarker test to predict the risk of premature birth

Waters Corp. inked a research partnership deal with an Irish research facility targeted toward developing a blood-based biomarker test that can predict whether a fetus is at high risk for premature birth.